Select for export Adverse events in clinical treatments with serotonergic psychedelics and MDMA: A mixed-methods systematic review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811221116926 PubMed 36017784 Copy citation Copy BibTeX Unknown journal 2022-08-25 Breeksema JJ, Kuin BW, Kamphuis J, van den Brink W, Vermetten E, Schoevers RA. Europe PMC Published psilocybin AnxietyHeadache / MigraineClinical Trial Systematic Review More
Select for export Comparison of psychedelic and near-death or other non-ordinary experiences in changing attitudes about death and dying. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1371/journal.pone.0271926 PubMed 36001643 Copy citation Copy BibTeX PLoS ONE 2022-08-23 Sweeney MM, Nayak S, Hurwitz ES, Mitchell LN, Swift TC, Griffiths RR. Europe PMC Published psilocybin SpiritualityMystical ExperienceObservational Study Observational Study More
Select for export Psychedelic drug abuse potential assessment research for new drug applications and Controlled Substances Act scheduling. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.neuropharm.2022.109220 PubMed 35987353 Copy citation Copy BibTeX Unknown journal 2022-08-16 Henningfield JE, Coe MA, Griffiths RR, Belouin SJ, Berger A, Coker AR Europe PMC Published psilocybin Mechanism of ActionConsciousnessSpirituality Other More
Select for export The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/07067437221111371 PubMed 35975555 Copy citation Copy BibTeX Unknown journal 2022-08-16 Rosenblat JD, Husain MI, Lee Y, McIntyre RS, Mansur RB, Castle D Europe PMC Published psilocybin DepressionAnxietyHeadache / Migraine Randomized Controlled Trial More
Select for export Policy considerations that support equitable access to responsible, accountable, safe, and ethical uses of psychedelic medicines. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.neuropharm.2022.109214 PubMed 35973601 Copy citation Copy BibTeX Unknown journal 2022-08-12 Belouin SJ, Averill LA, Henningfield JE, Xenakis SN, Donato I, Grob CS Europe PMC Published psilocybin Review Article Review Article More
Select for export Psilocybin Efficacy and Mechanisms of Action in Major Depressive Disorder: a Review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s11920-022-01361-0 PubMed 35953638 Copy citation Copy BibTeX Unknown journal 2022-08-11 Prouzeau D, Conejero I, Voyvodic PL, Becamel C, Abbar M, Lopez-Castroman J. Europe PMC Published psilocybin DepressionEnd-of-Life DistressMechanism of Action Clinical Trial More
Select for export Acute and long-term effects of psilocybin on energy balance and feeding behavior in mice. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41398-022-02103-9 PubMed 35953488 Copy citation Copy BibTeX Translational Psychiatry 2022-08-10 Fadahunsi N, Lund J, Breum AW, Mathiesen CV, Larsen IB, Knudsen GM Europe PMC Published psilocybin AddictionNeuroplasticityPharmacology Animal Study More
Select for export Differences across sexes on head-twitch behavior and 5-HT2A receptor signaling in C57BL/6J mice. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.neulet.2022.136836 PubMed 35963476 Copy citation Copy BibTeX Unknown journal 2022-08-09 Jaster AM, Younkin J, Cuddy T, de la Fuente Revenga M, Poklis JL, Dozmorov MG Europe PMC Published psilocybin DepressionAddictionPharmacology Animal Study More
Select for export The Watts Connectedness Scale: a new scale for measuring a sense of connectedness to self, others, and world. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-022-06187-5 PubMed 35939083 Copy citation Copy BibTeX Psychopharmacology 2022-08-07 Watts R, Kettner H, Geerts D, Gandy S, Kartner L, Mertens L Europe PMC Published psilocybin DepressionEmotional ProcessingClinical Trial Randomized Controlled Trial More
Select for export Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41398-022-02039-0 PubMed 35918311 Copy citation Copy BibTeX Translational Psychiatry 2022-08-01 Cavanna F, Muller S, de la Fuente LA, Zamberlan F, Palmucci M, Janeckova L Europe PMC Published psilocybin Brain ImagingMicrodosingWellbeing Other More
Select for export From Mushrooms to Myolysis: A Case of Rhabdo in Psilocybin-Induced Mood and Psychotic Disorder. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1097/nmd.0000000000001489 PubMed 35900779 Copy citation Copy BibTeX The Journal of Nervous and Mental Disease 2022-07-31 Suleiman M, Basu A, Belal S, Jacob T. Europe PMC Published psilocybin End-of-Life DistressMicrodosing Other More
Select for export Magic Mushrooms - an exploratory look at how mental health professionals feel and think about Psilocybin. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.psychres.2022.114727 PubMed 35878481 Copy citation Copy BibTeX Psychiatry Research 2022-07-15 Meyer TD, Meir P, Lex C, Soares JC. Europe PMC Published psilocybin DepressionEmotional ProcessingObservational Study Observational Study More
Select for export Psilocybin in neuropsychiatry: a review of its pharmacology, safety, and efficacy. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1017/s1092852922000888 PubMed 35811423 Copy citation Copy BibTeX Unknown journal 2022-07-10 Dodd S, Norman TR, Eyre HA, Stahl SM, Phillips A, Carvalho AF Europe PMC Published psilocybinpsilocin DepressionAnxietyPharmacology Review Article More
Select for export Psychedelic drugs for psychiatric disorders. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.jns.2022.120332 PubMed 35841696 Copy citation Copy BibTeX Unknown journal 2022-07-04 da Costa SC, Oesterle T, Rummans TA, Richelson E, Gold M. Europe PMC Published psilocybin DepressionAnxietyAddiction Clinical Trial More
Select for export A Single Method for 127 Recommended and Additional DUID Drugs in Blood and Urine by LC-MS-MS. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1093/jat/bkab075 PubMed 34159389 Copy citation Copy BibTeX Unknown journal 2022-06-30 Farley M, Tran H, Towler S, Gevorkyan J, Pearring S, Rodda LN. Europe PMC Published psilocin AddictionSafetyToxicity Qualitative Study More
Select for export Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41598-022-14512-3 PubMed 35773270 Copy citation Copy BibTeX Scientific Reports 2022-06-29 Rootman JM, Kiraga M, Kryskow P, Harvey K, Stamets P, Santos-Brault E Europe PMC Published psilocybin AgingMicrodosingObservational Study Observational Study More
Select for export Associations between classic psychedelics and nicotine dependence in a nationally representative sample. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41598-022-14809-3 PubMed 35732796 Copy citation Copy BibTeX Scientific Reports 2022-06-21 Jones G, Lipson J, Nock MK. Europe PMC Published psilocybin AddictionObservational Study Observational Study More
Select for export Sustained effects of single doses of classical psychedelics in humans. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41386-022-01361-x PubMed 35729252 Copy citation Copy BibTeX Unknown journal 2022-06-20 Knudsen GM. Europe PMC Published psilocybin DepressionAnxietyNeuroplasticity Review Article More
Select for export [Attitudes of Mental Health Experts Towards Psilocybin]. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1055/a-1846-1161 PubMed 35724682 Copy citation Copy BibTeX Fortschritte der Neurologie · Psychiatrie 2022-06-19 Schmidt C, Wolff M, Gründer G, Jungaberle H. Europe PMC Published psilocybin DepressionObservational Study Observational Study More
Select for export Psychedelics as preventive treatment in headache and chronic pain disorders. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.neuropharm.2022.109166 PubMed 35718005 Copy citation Copy BibTeX Unknown journal 2022-06-15 Schindler EAD. Europe PMC Published psilocybin Chronic PainHeadache / MigraineMechanism of Action Review Article More
